Part of a large multi-national regenerative medicine network operating more than eighty centers across eight countries.
This location is part of R3 Stem Cell, a regenerative medicine network that states it operates more than eighty centers across eight countries, including the United States, Mexico, the Philippines, Pakistan, India, Turkey, South Africa and the United Arab Emirates. Because it is a network rather than a single practice, the physicians, facilities and protocols can differ between locations.
The organization offers a wide range of biological products, including cells derived from adipose tissue, bone marrow and umbilical cord tissue, as well as exosome and platelet-rich plasma preparations. Its published condition list is unusually broad, covering orthopedic, neurological, autoimmune, cardiac, metabolic and cosmetic categories.
R3 states directly on its own website that stem cell therapy is experimental and not approved by the Food and Drug Administration in the United States — a disclosure worth noting, and one prospective patients should weigh alongside the breadth of conditions listed. The company reports having performed over 29,000 procedures and cites an 85 percent patient satisfaction figure; both are self-published and have not been independently verified.
The network lists the following. This range is very broad; ask what specific evidence supports use in your condition.
Individual treating physicians are not named for this location on the network website.
This record refers to the La Jolla and San Diego, California location within the R3 Stem Cell network, which operates 80+ centers across eight countries.
No procedure pricing is published. The company offers a no-cost consultation and references third-party financing through Lendvious in the United States and iFinance in Canada.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.